NDC 16714-952 – Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate

Dextroamphetamine Saccharate 3.75 mg/1; Amphetamine Aspartate Monohydrate 3.75 mg/1; Dextroamphetamine Sulfate 3.75 mg/1; Amphetamine Sulfate 3.75 mg/1 · Tablet · Oral

Human Prescription Drug DEA schedule CII

Product NDC16714-952

Product details

Brand name
Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate
Generic name
Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate
Labeler
NorthStar RxLLC
Dosage form
Tablet
Route
Oral
Marketing category
ANDA · ANDA202424
Marketed since
March 20, 2019
Listing expires
December 31, 2026
Pharmacologic class
Central Nervous System Stimulant; Central Nervous System Stimulant; Central Nervous System Stimulant; Central Nervous System Stimulant

Active ingredients

Uses, dosage, side effects and warnings for Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, and Amphetamine Sulfate →

Package NDC codes (1)

Package NDCDescriptionSince
16714-952-01100 TABLET in 1 BOTTLE (16714-952-01)Mar 20, 2019

Other Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate, and Amphetamine Sulfate products